Travelling to Basel, Switzerland for Informa Connect / EBD Group’s BIO-Europe Spring, taking place at the Messe Congress Center between the 20th and 22nd March, pharmaphorum listened to par
A recent Biomedical Research & Bio-Products AG phase 2 study showed that its TSST-1 vaccine is safe and effective against Staphylococcal-induced Toxic Shock Syndrome (
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
